ALK and neoplasm: Causes of resistance include tumor acquisition of a secondary mutation within the ALK tyrosine kinase domain, amplification of the ALK fusion gene (which may occur alone or in combination with a secondary resistance mutation), or development of alternative or bypass signaling pathways (Shaw & Solomon, 2014).